Video footage of some of our speakers’ presentations
We are pleased to provide videos of some of the conference presentations. Some speakers have required that the videos are only available to conference delegates; these videos are therefore password protected. If you were a delegate at Childhood Cancer 2016, you will receive the password by email; if not you can request it by emailing us.
Chair's introduction to day one:
Is precision medicine a reality for children with cancer in 2016?
The successes and future direction of paediatric cancer research and therapy
Lou Chesler: What is precision medicine?
The genomic landscape in childhood leukaemia and options for precision therapy
Our initiatives and strategy to implement precision therapy in the UK
Elisa Izquierdo Delgado:
Validation of a Next-Generation Sequencing assay for detecting actionable mutations in Paediatric Solid Tumours
Identification of distinct molecular characteristics in pediatric spinal ependymoma
Dose Individualisation based on therapeutic drug monitoring as a valuable tool in the application of precision medicine.
Yann Jamin: Non-invasive functional MRI biomarkers for the delivery of precision medicine for children with neuroblastoma
Non-invasive identification of molecular subgroup in medulloblastoma
Chair's introduction to Day two
The challenges of targeting the solid tumour wiht immune therapies
Antibody-based and Bispecific T-cell dependent therapies
Stephan A Grupp:
The CAR T cell revolution in cancer therapy
NCI CARs for childhood acute lymphoblastic leukaemia and neuroblastoma: the promise and potential pitfalls
Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia
Toward a targeted intravenous delivery platform for paediatric brain tumours by a harmless bacteria virus
Chair's introduction to day three
Making sense of genetic associations with childhood leukaemia risk
Childhood leukaemia and natural background radiation
What do we know about risk factors for childhood cancer and what are the challenges in ongoing research?
Primary prevention: Can we reduce exposure to risk factors associated with childhood leukaemia and other cancers?
NQO1, GSTM1 and GSTT1 polymorphisms are associated with childhood acute myeloid leukemia subtypes and type I mutations